16.9 C
United States of America
Saturday, May 28, 2022

COVID-19: Minsa reports 61 deaths and 5,332 new infections in the last 24 hours

The Ministry of Health (minsa) reported that today, Saturday, February 12, a total of 61 people died from the COVID-19. With this number, the death toll from the deadly virus in Peru rose by 208,120. In addition, it reported that infections increased by 10,859 (5,332 in the last 24 hours), bringing the total number of infected people to 3,435,753.

LOOK: COVID-19 in Lima and Callao: are social gatherings, bars and nightclubs allowed this February 12 and 13?

The Minsa also reported that there are a total of 3,967 hospitalized patients, of which 1,325 are on mechanical ventilation in the intensive care unit (ICU).

Vaccinations in Peru

So far, Peru has received more than 26 million vaccines from Sinopharm, more than 34 million from Pfizer, and more than 4 million from AstraZeneca. All of these are applied according to the programming by age groups established by the Government after prioritizing health personnel, older adults and members of the National Police, Armed Forces and Firefighters.

LOOK: Independence: Plaza Norte vaccination center reached one million inoculated against COVID-19

Vaccination in Peru began in February, after the arrival of the first batch of vaccines from China (Sinopharm). To date, vaccination continues throughout the country.

In Lima, Callao and regions, they are vaccinated from 5 to 11 years with comorbiditiesand from 10 onwards without comorbidities.



  • The consequences of the presence of Hernán Condori in vaccination
  • COVID-19: all regions nationwide will continue without a curfew until February 27
  • Juan Silva, the irremovable minister: the video that explains the pending agreements in the MTC
  • Lima Expresa: reactions to the increase in the toll rate that will take effect from this Sunday
  • Endless queues to obtain license, passport and DNI: What to do if it happens to you?

Latest news
- Advertisement -
Related news


Please enter your comment!
Please enter your name here